PAPILLONEURITIS (PAPILLITIS) AS THE INITIALMANIFESTATION OF MULTIPLE SCLEROSIS IN A YOUNG WOMAN- A CASE REPORT
Abstract
Introduction: The optic neuritis occurs due to inflammatory and demyelinating disorders of the optic nerve. Papilloneuritis is part of the diagnosis of multiple sclerosis because it is its first manifestation. Case report: A patient admits for examination at the University Clinic for Eye Diseases, reporting a sudden decrease in vision in her left eye three days ago, accompanied by long-lasting headaches.The best visual acuity at a distance was 1.0 in the right eye, and the left eye had a visual acuity of counting fingers in front of the eye without correction. Intraocular pressure was normal in both eyes. Examination of the anterior segment of the eye with a biomicroscope did not reveal any changes. Examination of the posterior segment reveals an edematous optic nerve head, above the level of the retina, with blurred margins, without the presence of physiological excavation. Retinal veins are congested and tortuous, and retinal arteries have a narrower lumen. Macula lutea has a weakened foveolar reflex. The Ishihara test showed color desaturation, significantly reduced in the left eye, which is evidence of nerve dysfunction. An optical coherence tomography slide showed an increased peripapillary thickening of the retinal nerve fiber layer of 105 um and increased central foveal thickness of 313 um. The visual field examination of the left eye showed central and paracentral defects. Laboratory results were within normal limits. The patient was referred for a neurological examination.Additional tests were performed: magnetic resonance imaging of the head, visual evoked potentials, and somatosensory potentials to facilitate the disease diagnosis and the treatment initiation. Conclusion: Early corticosteroid therapy led to stabilization of the condition.
Keywords: papilloneuritis (papillitis), optic neuritis, multiple sclerosis, OCT, visual field, VEP, MRI.
References
Treatment Trial. Arch Ophthalmol. 1991;109(12):1673– 1678.
2. Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in
the treatment of acute optic neuritis. N Engl J Med. 1992;326(9):581– 588.
3. Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med. 2006;354(12):1273– 1280.
4. Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83– 99.
5. Frohman EM, Frohman TC, Zee DS, McColl R, Galetta S. The neuro-ophthalmology of multiple
sclerosis. Lancet Neurol. 2005;4(2):111– 121.
6. Petzold A, de Boer JF, Schippling S, et al. Optical coherence tomography in multiple sclerosis: a
systematic review and meta-analysis. Lancet Neurol. 2010;9(9):921– 932.
7. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple
sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann
Neurol. 2001;50(1):121– 127.
8. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of
the McDonald criteria. Lancet Neurol. 2018;17(2):162– 173.
9. Costello F. The role of optical coherence tomography in a neuro-ophthalmology practice. Saudi J
Ophthalmol. 2011;25(2):185– 191.
10. Klistorner A, Garrick R, Barnett MH, Graham SL, Arvind H, Sriram P. Axonal loss in non-optic
neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential.
Neurology. 2013;80(3):242– 245.